1. Home
  2. UTSI vs VYNE Comparison

UTSI vs VYNE Comparison

Compare UTSI & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UTStarcom Holdings Corp.

UTSI

UTStarcom Holdings Corp.

HOLD

Current Price

$2.49

Market Cap

22.9M

ML Signal

HOLD

Logo VYNE Therapeutics Inc.

VYNE

VYNE Therapeutics Inc.

HOLD

Current Price

$0.63

Market Cap

20.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTSI
VYNE
Founded
1991
2003
Country
China
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
20.4M
IPO Year
1999
2017

Fundamental Metrics

Financial Performance
Metric
UTSI
VYNE
Price
$2.49
$0.63
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
5.0K
129.9K
Earning Date
03-24-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.29
52 Week High
$2.94
$1.98

Technical Indicators

Market Signals
Indicator
UTSI
VYNE
Relative Strength Index (RSI) 53.66 59.63
Support Level $2.34 $0.56
Resistance Level $2.57 $0.75
Average True Range (ATR) 0.10 0.02
MACD 0.02 0.00
Stochastic Oscillator 53.33 99.82

Price Performance

Historical Comparison
UTSI
VYNE

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.

Share on Social Networks: